Table 1.
Clinical characteristics of COVID-19 patients.
| Characteristic | S.Ch | S.Ad | C.Ad |
|---|---|---|---|
| Symptoms | |||
| Fever | 8 (72.73%) | 6 (50%) | 8 (47%) |
| Chills | 8 (72.73%) | 6 (50%) | 8 (47%) |
| Weakness | 4 (36.36%) | 2 (16.6%) | 5 (29.4%) |
| Lethargy | 4 (36.36%) | 6 (50%) | 5 (29.4%) |
| Myalgia | – | 5 (41%) | – |
| Dyspnea | 1 (9.09%) | 11(91.6%) | 12 (70.5%) |
| Tachypnea | 1 (9.09%) | – | – |
| Sore throat | 1 (9.09%) | – | – |
| Dry cough | 6 (54.55%) | 5 (41%) | 5 (29.4%) |
| Anorexia | 1 (9.09%) | 6 (50%) | 5 (29.4%) |
| Abdominal pain | 1 (9.09%) | 1 (8.3%) | – |
| Nausea and vomiting | 2 (18.18%) | 3 (25%) | 2 (11.7%) |
| Diarrhea | – | 1 (8.3%) | – |
| Ischemia | 1 (9.09%) | – | 1 (5.8%) |
| Headache | – | – | 2 (11.7%) |
| Radiography | |||
| Ground-glass opacity | 1 (9.09%) | 12 (100%) | 17 (100%) |
| Linear opacity | 3 (27.27%) | – | – |
| Patchy opacity | 1 (9.09%) | 9 (75%) | 12 (70.5%) |
| Atelectasis | 1 (9.09%) | – | – |
| Pleural effusion | 1 (9.09%) | – | – |
| Mild segmental atelectasis | 1 (9.09%) | – | – |
| Consolidation | – | 1 (8.3%) | 9 (52.9%) |
| Comorbidities | |||
| Malignancy | – | – | 2 (11.7%) |
| Hypertension | – | 5 (41%) | 7 (41.1%) |
| Diabetes | – | 3 (25%) | 7 (41.1%) |
| Cardiovascular disease | – | 1 (8.3%) | 3 (17.6%) |
| Chronic kidney disease | – | – | 1 (5.8%) |
| Pulmonary disease | – | 1 (8.3%) | 1 (5.8%) |
| Cerebrovascular disease | – | – | 1 (5.8%) |
| Mortality rate | 1 (9.09%) | 1 (8.3%) | 11 (64.7%) |
COVID-19,coronavirus 2019; S.Ch, severe child; S.Ad, severe adult; C.Ad, critical adult.
Data are the frequency of individuals (percentage).